Delivery Order SPE2DB22D1002-SPE2DB25FLHY5
- Not listed
- The Defense Logistics Agency awarded a $30,940.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe units (0.5ML) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply delivery to support federal medical procurement needs. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringes. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive, non-set-aside award to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $12,901.75 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine syringes (0.5 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $5,908.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringe format on September 26, 2025, with completion scheduled for September 29, 2025. This non-competed delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $35,155.89 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PREVNAR 20 syringe units (0.5ML). This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open market solicitation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a $16,049.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) with an ultimate completion date of September 4, 2025. This non-set-aside competitive award was issued on September 3, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a $39,581 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5 mL syringes. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,250.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringe format on September 11, 2025, with completion targeted for September 12, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,170.98 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 16, 2025, with completion scheduled for June 17, 2025. This non-competed delivery order represents a firm fixed price transaction processed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) under a firm fixed-price contract valued at approximately $217K. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a direct procurement of this pneumococcal vaccine product for military and federal healthcare systems. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHY5Delivery Order
The Defense Logistics Agency awarded a $24,897 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on September 22, 2025, with completion scheduled for September 23, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion blanket purchase agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare systems globally. The order will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups and is a standard component of military medical supply chains. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. The delivery order demonstrates the company's continued role as a primary vendor for DLA's medical supply chain supporting military readiness and personnel health requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 9/22/25 |